Byrne Financial Freedom’s Columbia Research Enhanced Core ETF RECS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.33M Buy
192,408
+1,896
+1% +$80.3K 3.25% 5
2026
Q1
$7.43M Sell
190,512
-8,853
-4% -$359K 3.55% 7
2025
Q4
$8.14M Buy
199,365
+52,192
+35% +$2.12M 3.74% 6
2025
Q3
$5.94M Buy
147,173
+73,240
+99% +$2.82M 2.96% 11
2025
Q2
$2.72M Buy
73,933
+56,689
+329% +$1.92M 1.36% 22
2025
Q1
$573K Buy
17,244
+11,030
+178% +$384K 0.33% 50
2024
Q4
$215K Buy
+6,214
New +$218K 0.1% 92

Other funds holding RECS

Byrne Financial Freedom's RECS Position: Q2 2026 in Review

Byrne Financial Freedom increased its Columbia Research Enhanced Core ETF (RECS) stake by 1% in Q2 2026, buying an estimated $80.3K and bringing the position to 192,408 shares worth $8.33M. The position accounts for 3.25% of the portfolio, ranked #5.

Byrne Financial Freedom first reported a position in RECS in Q4 2024 and has held it in 7 quarters since. 186 funds tracked by Wall St. Rank hold RECS as of Q2 2026.

  • Byrne Financial Freedom held 192,408 shares of Columbia Research Enhanced Core ETF worth $8.33M as of Q2 2026.
  • Byrne Financial Freedom bought 1,896 Columbia Research Enhanced Core ETF shares in Q2 2026, an estimated $80.3K.
  • Columbia Research Enhanced Core ETF made up 3.25% of Byrne Financial Freedom's portfolio in Q2 2026, its #5 holding.
  • Byrne Financial Freedom first reported a position in Columbia Research Enhanced Core ETF in Q4 2024 and has held it in 7 quarters since.
  • 186 funds tracked by Wall St. Rank held Columbia Research Enhanced Core ETF as of Q2 2026.

Based on Byrne Financial Freedom's 13F filing for Q2 2026, filed 30 Jul 2026.